<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04187274</url>
  </required_header>
  <id_info>
    <org_study_id>P2019323</org_study_id>
    <nct_id>NCT04187274</nct_id>
  </id_info>
  <brief_title>Evaluation of the IKORUS Technology in Patients Undergoing Major Abdominal Surgery</brief_title>
  <official_title>Evaluation of the Urethral Photoplethysmography-derived Perfusion Device (IKORUS) in Patients Undergoing Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this observational substudy is to evaluate the feasibility, performance and&#xD;
      behavior of the IKORUS (Advanced Perfusion Diagnostics, Villeurbanne, France), a new tissue&#xD;
      perfusion device using urethral photoplethysmography in patients undergoing major abdominal&#xD;
      surgery and in whom an advanced hemodynamic monitoring is placed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continuous monitoring of tissue perfusion in patients undergoing major surgery remains&#xD;
      challenging because of the lack of tools available. Through using urethral&#xD;
      photoplethysmography, the urethral perfusion index (uPI) could allow tissue perfusion&#xD;
      monitoring through a modified urinary catheter. The goal of this observational study is to&#xD;
      evaluate the feasibility , performance and behavior of the IKORUS (Advanced Perfusion&#xD;
      Diagnostics, Villeurbanne, France), a new device in the field. We aimed to assess its&#xD;
      performance (duration and signal quality), the uPI variations during hemodynamic events&#xD;
      (fluid challenge) in patients undergoing major abdominal surgery and equipped with an&#xD;
      advanced hemodynamic monitoring.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 4, 2019</start_date>
  <completion_date type="Actual">July 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of uPi evolution during surgery and comparison with Stroke volume</measure>
    <time_frame>during surgery</time_frame>
    <description>Percentage of case time with positive correlation between both variables (positive or negative) during a fluid challenge and during the whole case</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of decreased perfusion during surgery</measure>
    <time_frame>during surgery</time_frame>
    <description>Occurrence of decreased perfusion during surgery</description>
  </secondary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Technology</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IKORUS technology</intervention_name>
    <description>Ikorus technology is a new micro perfusion device measuring via urethral photoplethysmography, the urethral perfusion index (uPI) in patients equipped with an urinary catheter.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major abdominal surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adult patients undergoing major abdominal surgeries and equipped with an advanced&#xD;
             hemodynamic monitoring for goal directed therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Atrial fibrillation&#xD;
&#xD;
          -  Ejection fraction &lt; 30%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JOOSTEN ALEXANDRE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ERASME</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <state>Brussel-hoofdstad</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 1, 2019</study_first_submitted>
  <study_first_submitted_qc>December 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2019</study_first_posted>
  <last_update_submitted>September 18, 2020</last_update_submitted>
  <last_update_submitted_qc>September 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Alexandre Joosten, MD PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

